A systematic review concluded that while genomic classifier (GC) tests could affect risk classifications or treatment choices for patients with localized prostate cancer (PCa), more research is ...

Doctors often use tests like prostate-specific antigen levels and Gleason scores to help decide how to treat it. Genomic tests look at the genes of the cancer cells, which can give doctors a ...

OncoAssure’s prostate test – a molecular clinical risk score – was found to predict risk for aggressive disease and cancer progression better than standard clinical and pathological information.

Prostate cancer is one of the most common types of cancer in men. Doctors often use tests like prostate-specific antigen levels and Gleason scores to help decide how to treat it.